腦血管支架市場規模、佔有率和成長分析（按材料、最終用戶和地區）- 產業預測 2025-2032

2023年全球腦血管支架市場規模價值4億美元，預計將從2024年的4.3億美元成長到2032年的8.2億美元，預計在預測期內（2025-2032年）的複合年成長率為8.3%。

由於腦部疾病發生率不斷上升和人口老化，預計腦血管支架市場將顯著成長。這些微小的網狀管對於治療腦動脈瘤和確保狹窄動脈的正常血流至關重要，隨著微創手術技術越來越普及，它們的應用也越來越廣泛。醫療技術的創新以及可生物吸收支架的採用預計將為市場參與者提供充足的機會。然而，某些支架高成本和潛在的手術併發症等挑戰可能會抑制市場擴張。此外，越來越多的監管機構核准新療法，可能會刺激對腦血管支架的需求，從而在未來創造一個充滿希望的市場。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析

腦血管支架市場規模（按材料和複合年成長率） (2025-2032)

• 市場概況
• 鉭
• 不銹鋼
• 鎳鈦合金

腦血管支架市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 門診手術中心
• 醫療中心
• 其他

腦血管支架市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Stryker Corporation（USA）
• Johnson & Johnson（USA）
• MicroPort Scientific Corporation（China）
• Penumbra, Inc.（USA）
• Asahi Intecc Co., Ltd.（Japan）
• Integer Holdings Corporation（USA）
• B. Braun Melsungen AG（Germany）
• Biotronik SE & Co. KG（Germany）
• Merit Medical Systems, Inc.（USA）
• Kaneka Medix Corp.（Japan）
• Acandis GmbH（Germany）
• Balt（Switzerland）
• Rapid Medical（Israel）
• Medinol Ltd.（Israel）

結論和建議

Global Cerebral Vascular Stent Market size was valued at USD 0.4 billion in 2023 and is poised to grow from USD 0.43 billion in 2024 to USD 0.82 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The cerebral vascular stent market is poised for significant growth, driven by the rising prevalence of cerebral disorders and an aging population. These small mesh tubes, crucial for treating brain aneurysms and ensuring proper blood flow in constricted arteries, are increasingly utilized as minimally invasive surgical techniques gain traction. Innovations in healthcare technology, along with the adoption of bioabsorbable stents, are expected to present ample opportunities for market players. However, challenges such as the high costs of certain stents and potential procedural complications may restrain market expansion. Moreover, increased regulatory approvals for novel treatments will likely enhance the demand for cerebral vascular stents, positioning the market for a promising future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cerebral Vascular Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cerebral Vascular Stent Market Segmental Analysis

Global Cerebral Vascular Stent Market is segmented by Material, End User and region. Based on Material, the market is segmented into Tantalum, Stainless Steel and Nitinol. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Medical Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cerebral Vascular Stent Market

The rising global geriatric population is a significant driving force behind the expansion of the cerebral vascular stent market. As the number of elderly individuals continues to grow, so does their susceptibility to various cerebral and vascular conditions that necessitate medical interventions. This increasing demographic trend implies a higher demand for cerebral vascular stents to address the health needs of older patients. Consequently, healthcare providers and manufacturers are likely to focus on developing and delivering innovative stenting solutions to cater to the unique requirements of this aging population, ultimately contributing to market growth in the sector.

Restraints in the Global Cerebral Vascular Stent Market

Restraints on the global cerebral vascular stent market include the significant costs associated with cerebral procedures. Surgical interventions involving the brain can be prohibitively expensive due to the requirement for advanced medical technology and the expertise of highly trained healthcare professionals. As a result, these elevated costs are anticipated to hinder the sales growth of cerebral vascular stents in the coming years. Patients may be deterred from undergoing necessary procedures due to financial constraints, ultimately impacting the overall market dynamics and limiting accessibility to crucial treatments for cerebral vascular conditions.

Market Trends of the Global Cerebral Vascular Stent Market

The Global Cerebral Vascular Stent market is experiencing a significant shift towards innovative materials, particularly bioabsorbable stents, which offer the dual benefits of effective vascular support and post-treatment absorption, thereby minimizing the risk of long-term complications. This trend is complemented by the increasing demand for drug-eluting stents that release therapeutic agents, further enhancing treatment outcomes. Together, these developments are fostering a wave of advanced solutions aimed at improving patient safety and recovery. As manufacturers invest in research and development to integrate bioabsorbable materials with drug-eluting technology, the market is poised for substantial growth, driven by enhanced patient-centric solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cerebral Vascular Stent Market Size by Material & CAGR (2025-2032)

• Market Overview
• Tantalum
• Stainless Steel
• Nitinol

Global Cerebral Vascular Stent Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Medical Centres
• Others

Global Cerebral Vascular Stent Market Size & CAGR (2025-2032)

• North America (Material, End User)
  • US
  • Canada
• Europe (Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Medix Corp. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medinol Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations